Study Stopped
Was not able to recruit the total anticipated number of subjects
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
1 other identifier
observational
4
1 country
1
Brief Summary
The purpose of this study is:
- To study the components of the gastroesophageal junction high-pressure zone individually and as a group, by pharmacologically eliminating or accentuating the pressure profile generated by the smooth muscle components.
- To differentiate the gastric sling fibers from the clasp fibers based on the spatial orientation of these muscle groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2008
CompletedFirst Posted
Study publicly available on registry
August 20, 2008
CompletedStudy Start
First participant enrolled
April 12, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2017
CompletedFebruary 22, 2019
February 1, 2019
2 years
August 18, 2008
February 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure at the gastric sling and clasp fibers
esophageal and gastroesophageal junction Pressure at the gastric sling and clasp fibers
5 years
Study Arms (3)
Normal Control
Normal control subjects are the participants with no history of GERD, no signs and symptoms of GERD
GERD Patients
GERD patients are those with history of GERD, signs and symptoms of GERD and selected signs and symptoms of GERD in the questionnaire.
Barrett's patients
Barrett's patients are those participants who in addition to all the qualities of GERD patients have long standing history of GERD and mucosal changes in the esophagus.
Eligibility Criteria
Normal control subjects without GERD and patients with GERD
You may qualify if:
- Symptomatic heartburn
- Regurgitation
- Chest pain or water brash
You may not qualify if:
- Medications-Subjects on any medication which could effect the gastroesophageal junction high-pressure zone will be excluded, this includes use of antacids, H2 blockers, proton pump inhibitors, prokinetic agents, erythromycin type antibiotics and anticholinergics.
- GI symptoms, conditions and disorders
- Esophagitis
- Gastrointestinal symptoms such as abdominal pain
- Heartburn
- Reflux
- Regurgitation
- Chest pain
- Difficulty swallowing
- Pain on swallowing
- Dysphagia
- Abdominal surgery involving the stomach or esophagus
- Nausea or vomiting
- Diabetes
- Scleroderma
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
Study Sites (1)
LIJ Medical Center- NSLIJ Health System
New Hyde Park, New York, 11040, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larry S Miller, MD
Feinstein Institute for Medical Research
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 18, 2008
First Posted
August 20, 2008
Study Start
April 12, 2013
Primary Completion
April 9, 2015
Study Completion
February 3, 2017
Last Updated
February 22, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share